8-K: Know Labs Faces Delisting Threat After Failing to Meet NYSE American Equity Requirements

Know Labs has received a notice from the NYSE American for not meeting minimum stockholders' equity requirements and must submit a plan to regain compliance by October 27, 2024.

Summary

• Know Labs has been notified by the NYSE American that it is not in compliance with continued listing standards due to insufficient stockholders' equity.
• The company's stockholders' deficit was $4.6 million as of June 30, 2024, and it has reported losses in the last five fiscal years.
• NYSE American requires a minimum of $4 million in stockholders' equity if a company has losses in three of the last four fiscal years, and $6 million if losses occurred in the last five fiscal years.
• Know Labs must submit a plan by October 27, 2024, to regain compliance by March 27, 2026.
• If the plan is accepted, the company will continue to be listed while under periodic review; if not, delisting procedures will commence.
• The notice does not immediately affect the trading of Know Labs' stock, but it will have a '.BC' designation to indicate its non-compliance status.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice and the company's financial struggles. While there are plans to regain compliance, the uncertainty and risk of delisting weigh heavily on the outlook.

Positives

• The company intends to submit a plan to regain compliance with NYSE American listing standards.
• The company's stock will continue to trade on the NYSE American while the plan is being implemented.
• The company believes upcoming business progress and technological development, including potential partnerships, will improve its valuation.

Negatives

• Know Labs is not in compliance with NYSE American listing standards due to a stockholders' deficit of $4.6 million.
• The company has reported losses in the last five fiscal years.
• There is a risk of delisting if the compliance plan is not accepted or if the company fails to meet the standards by March 27, 2026.

Risks

• The company faces the risk of delisting if its compliance plan is not accepted by the NYSE American.
• There is no guarantee that the company will be able to regain compliance within the required timeframe.
• The company's stock price may be negatively impacted by the delisting notice and the '.BC' designation.
• The company's ability to secure strategic and joint venture partnerships is uncertain.

Future Outlook

The company plans to submit a compliance plan based on expected business progress, technological development, and potential partnerships, but there is no assurance of regaining compliance within the required timeframe.

Management Comments

• The company intends to submit a plan to regain compliance with NYSE American listing standards.
• The company believes that upcoming business progress and technological development will improve its valuation.
• The company expects to make positive announcements regarding strategic and joint venture partnerships.

Industry Context

This announcement highlights the challenges faced by companies with consistent losses in maintaining their stock exchange listings, particularly for smaller companies that may not have the same access to capital as larger, more established firms. It also underscores the importance of financial health and compliance with exchange rules.

Comparison to Industry Standards

• Many companies in the biotech and medical device sectors, especially those in the development stage, face challenges in maintaining profitability and meeting listing requirements.
• Companies like Senseonics (SENS) and Dexcom (DXCM), which are also involved in glucose monitoring technology, have faced similar challenges in their early stages but have managed to achieve compliance and growth.
• The requirement for minimum stockholders' equity is a standard benchmark for exchanges to ensure the financial stability of listed companies, and Know Labs' failure to meet this standard is a significant concern.

Stakeholder Impact

• Shareholders face the risk of delisting and potential loss of investment value.
• Employees may experience uncertainty about the company's future.
• Customers may be concerned about the company's ability to deliver on its products and services.
• Suppliers and creditors may be concerned about the company's financial stability.

Next Steps

• Know Labs must submit a compliance plan to the NYSE American by October 27, 2024.
• The company will be subject to periodic reviews by the NYSE American staff if the plan is accepted.
• The company will continue to work on business progress and technological development, including potential partnerships.

Key Dates

Keywords

delisting, NYSE American, stockholders equity, compliance, listing standards, financial deficit, KNW, non-compliance